🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This is a two stage study, with an initial dose escalation phase I study an...
Status
Active Not Recruiting
Location
Velindre NHS Trust
Start Date
2014-05-07
Trial ID
NCT01992952
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested
This is a multicentre phase-III-trial to evaluate the use of capivasertib i...
Status
Recruiting
Location
Institut Jules Bordet
Start Date
2025-11-27
Trial ID
NCT07281833
Treatments Being Tested
This is a two-part, open-label, randomized, crossover study in healthy subj...
Status
Completed
Location
Research Site
Start Date
2021-07-26
Trial ID
NCT04944771
Treatments Being Tested
This study is a single arm, single center phase II study of AZD5363 in comb...
Status
Completed
Location
Samsung Medical Center
Start Date
2015-01-07
Trial ID
NCT02451956
Treatments Being Tested
This study is designed to determine the efficacy and safety of durvalumab i...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-21
Trial ID
NCT03742102
Treatments Being Tested
A cross-sectional, non-interventional, observational study using qualitativ...
Status
Completed
Location
Research Site
Start Date
2025-07-31
Trial ID
NCT07008963
Treatments Being Tested
This is a global, multicenter, open-label, randomized Phase 3 study compari...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2025-08-26
Trial ID
NCT06982521
Treatments Being Tested
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combin...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-10-11
Trial ID
NCT03616587
Treatments Being Tested